You are here: Industry Insights > Sanofi

News List

Sanofi Announces Organizational Change americanpharmaceuticalreview
September 14, 2018
Sanofi announced it will change the organizational structure of two of its Global Business Units (GBU).
After FDA about-face, Amicus' Galafold nabs Fabry disease nod to challenge Sanofi fiercepharma
September 13, 2018
Amicus priced Galafold at $315,000, a slight discount from Sanofi's competitor Fabarazyme, and promised to keep future price increase below the CPI.
Hu-manity.co launches blockchain app to help users sell their healthcare data fiercebiotech
September 07, 2018
Built with IBM’s blockchain technology, the ledger will log people’s authorization for commercial use of their personal information and allow them to choose to share it for specific research purposes. (Pixabay / Geralt)
Sanofi agrees on monetary settlement for bribery charges pharmaceutical-technology
September 06, 2018
Sanofi has agreed on a civil settlement with the US Securities and Exchange Commission (SEC) to resolve charges related to allegations of its subsidiaries paying bribes to win contracts.
Sanofi Reaches Civil Settlement with US SEC americanpharmaceuticalreview
September 06, 2018
Sanofi has reached a civil settlement with the U.S. Securities and Exchange Commission (SEC) fully resolving the SEC's investigation into possible violations of the U.S. Foreign Corrupt Practices Act.
Sanofi wins European approval for rare blood-clotting disorder treatment financialexpress
September 05, 2018
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in June had recommended the approval of caplacizumab, which is to be prescribed to adults suffering acquired thrombotic thrombocytopenic purpura (aTTP)
No-deal Brexit airlift? Sanofi may have to fly flu shots into the U.K. for the 2019-20 season fiercepharma
August 21, 2018
Several drugmakers are already stockpiling drugs in case of a no-deal Brexit. However, one crucial product simply cannot be reserved because it’s not possible to be made in advance: the seasonal flu vaccine.
Citing appeals court 'anarchy,' Amgen asks SCOTUS to weigh its PCSK9 patent spat with Sanofi fiercepharma
August 10, 2018
Amgen made an aggressive legal bid to push Sanofi and Regeneron's rival PCSK9 drug off the market when the two were first duking it out in 2015. It didn't work—but Amgen hasn't given up. It's aiming to take the battle to the U.S. Supreme Court instead.
Sanofi join AstraZeneca and MSD in stockpiling medicines, 1800 jobs at risk pharmafile
August 07, 2018
French multinational Sanofi have begun stockpiling drugs in preparation for a no-deal Brexit.
Sanofi diabetes executive makes the jump to Omeros to become CMO fiercebiotech
August 03, 2018
In keeping with the recent trend of top R&D executives moving to smaller biotechs, Sanofi’s Eckhard Leifke, M.D., the giant’s global head of diabetes late-stage development......

Previous page 1 2 3 4 5 6 7 8 9 10 ... 43 44 Next page